Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | HTT | P42858 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.37 |
| ▸ | CHUK | O15111 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16272268 | 0.86 | ALDH1A1 (0.43) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL1911140 | 0.81 | ALDH1A1 (0.45) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL11815643 | 0.81 | ALDH1A1 (0.49) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL23885286 | 0.77 | ALDH1A1 (0.42) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL3330505 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL3330500 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL15057387 | 0.76 | ALDH1A1 (0.41) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL15103671 | 0.76 | MAPT (0.41) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL16485936 | 0.76 | ALDH1A1 (0.64) | ALDH1A1HTTGAARAB9AMAPT | |
| SCHEMBL8568179 | 0.76 | ALDH1A1 (0.53) | ALDH1A1HTTGAARAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230276701-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DEVICE | OSAKA UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276701-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DEVICE | ESR1, ECE1, ESYT1 | ALDH1A1 722/4885HTT 1125/4885GAA 4006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.